内镜鼻窦手术治疗成人慢性鼻窦炎的长期结局
该观察性队列纳入59例接受内镜鼻窦手术(ESS)的成人慢性鼻窦炎(CRS)患者,前瞻性随访平均10.9年(±13.8个月)。结果显示生活质量(QOL)在术后6个月显著改善并持续至10年,健康效用值(HUV)恢复至正常,10年内修正手术率为17%,伴鼻息肉者修正手术率为25%,术后新发哮喘率为每年0.8%。
要点
- ESS术后6个月的QOL改善可持续至10年,超过75%患者报告有临床意义的长期QOL和HUV改善。
- 10年随访期间修正手术率为17%,伴鼻息肉者修正手术率为25%。
- 术后新发哮喘率为每年0.8%,多数患者愿意再次接受ESS并向他人推荐该手术。
核心结论
- ESS治疗CRS的10年前瞻性结局显示,术后6个月出现的初始临床显著QOL改善在长期内持续存在。
- 超过75%的患者报告有临床意义的长期QOL和HUV改善,HUV恢复至正常。
- 修正手术率为17%,且初次ESS后18个月内较差的术后内镜评分与更高的修正手术可能性相关。
- 多数患者愿意再次接受ESS并向其他考虑该治疗选择的患者推荐该手术。
研究设计与样本
- 观察性队列研究,纳入2004年至2008年间选择接受ESS的59例成人CRS患者。
- 采用描述性统计和简单固定效应线性模型分析长期疾病特异性生活质量(QOL)结局、健康效用值(HUV)、修正手术率、哮喘发生以及患者期望/满意度。
主要发现
- 59例成人患者平均随访10.9年(±13.8个月)。
- 平均QOL在基线至6个月间显著改善,并持续至10年。
- HUV改善至正常。
- 10年随访期内修正手术率为17%,伴鼻息肉者修正手术率为25%。
- ESS后新发哮喘发生率为每年0.8%,患者对ESS结局的满意度总体较高。
关键数值与推荐
- 10年随访期内修正手术率为17%,伴鼻息肉者修正手术率为25%。
- ESS后新发哮喘发生率为每年0.8%。
- 超过75%的患者报告有临床意义的长期QOL和HUV改善。
- 初次ESS后18个月内较差的术后内镜评分与更高的修正手术可能性相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a striking lack of long-term, prospective outcomes data for endoscopic sinus surgery (ESS) in chronic rhinosinusitis (CRS) using validated instruments. Our primary objective in this study was to report long-term outcomes (>10 years) after ESS for CRS obtained by prospective data collection. METHODS: An observational cohort (n = 59) of adult patients with CRS electing ESS was enrolled between 2004 and 2008. Long-term, disease-specific quality-of-life (QOL) outcomes, health utility values (HUV), revision surgery rate, development of asthma, and patient expectations/satisfaction with outcomes of ESS were examined using descriptive statistics and simple fixed-effects linear modeling. RESULTS: Fifty-nine adult patients were followed for 10.9 years (±13.8 months), on average. Mean QOL significantly improved between baseline and 6 months and remained durable to 10 years. HUV improved to normal. A 17% revision surgery rate within the 10-year follow-up period was observed with a 25% revision rate in CRS with polyposis. New-onset asthma after ESS occurred at a rate of 0.8%/year. Patient satisfaction with ESS outcomes was generally high. CONCLUSIONS: Ten-year prospective outcomes of ESS for CRS demonstrate that the initial clinically significant improvements in QOL seen 6 months postoperatively are durable over the long term. Over 75% of patients reported clinically significant long-term QOL and HUV improvement. HUV returned to normal. Revision surgery rate was 17% and worse postoperative endoscopy scores within 18 months of initial ESS were associated with higher likelihood of revision surgery. Most patients would pursue ESS again and recommend the procedure to other patients considering this treatment option.
引用
- Smith TL, Schlosser RJ, Mace JC, et al. Long-term outcomes of endoscopic sinus surgery in the management of adult chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019. PMID: 31207172. doi:10.1002/alr.22369
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。